Literature DB >> 21964469

CB1 receptor-deficient mice as a model for depression.

O Valverde1, M Torrens.   

Abstract

In the last 10 years, numerous experimental studies have revealed the participation of the endocannabinoid system in the control of emotional behavior and mood through the activation of the CB1 cannabinoid receptors. Endocannabinoids are able to exert a regulative control of different physiological mechanisms that are impaired during mood disorders, including monoaminergic system, the activity of pituitary-adrenal axis, the release and activation of neurotrophic factors that promotes neuroplasticity and adapted behavior, and probably neuroinflammatory cytokines release during the depressive disorders. Considering the body of elements that acts under the control of the endocannabinoid system and the key role played by the activation of the CB1 cannabinoid receptors in the control of emotion and mood, we had proposed that genetically modified mice lacking the CB1 cannabinoid receptors could represent a genetic model for depression. These animals generated by three distinct laboratories behave normally under basal conditions, but they could display an altered behavior under adverse environmental conditions. In this review, we have integrated most of the study that have been developed using mice lacking CB1 cannabinoid receptor for the studies of emotional responses. We have focused our attention not only in the data obtained using different behavioral paradigms, but also in different biomarkers that have been classically or recently associated to mood disorders, such as the deregulation of the serotonergic system, the reported impairment in neurotrophic factors and plasticity function described for depression, the alterations in the pituitary-adrenal axis function, and the lately reported role for inflammatory factors in the mood regulation. Finally, clinical studies support and confirm the obtained findings in animal models and lead us to propose that mice lacking CB1 cannabinoid receptor could represent a validate and appropriate model to evaluate depressive-like disorders in animals. Copyright Â
© 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21964469     DOI: 10.1016/j.neuroscience.2011.09.031

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  39 in total

1.  Estrous cycle and sex affect cocaine-induced behavioural changes in CD1 mice.

Authors:  Mariangela Martini; Ana Xavier Pinto; Olga Valverde
Journal:  Psychopharmacology (Berl)       Date:  2014-01-23       Impact factor: 4.530

Review 2.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

3.  Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders.

Authors:  Susana Mato; Fuencisla Pilar-Cuéllar; Elsa M Valdizán; Javier González-Maeso; Rafael Rodríguez-Puertas; Javier Meana; Joan Sallés; Benedicto Crespo-Facorro; Ángel Pazos
Journal:  Biochem Pharmacol       Date:  2018-08-10       Impact factor: 5.858

4.  Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.

Authors:  B A S Reyes; A F Carvalho; P Szot; D J Kalamarides; Q Wang; L G Kirby; E J Van Bockstaele
Journal:  Exp Neurol       Date:  2017-03-21       Impact factor: 5.330

5.  Role of CB2 receptors in social and aggressive behavior in male mice.

Authors:  Marta Rodríguez-Arias; Francisco Navarrete; M Carmen Blanco-Gandia; M Carmen Arenas; María A Aguilar; Adrián Bartoll-Andrés; Olga Valverde; José Miñarro; Jorge Manzanares
Journal:  Psychopharmacology (Berl)       Date:  2015-04-29       Impact factor: 4.530

Review 6.  Consequences of Perinatal Cannabis Exposure.

Authors:  Andrew F Scheyer; Miriam Melis; Viviana Trezza; Olivier J J Manzoni
Journal:  Trends Neurosci       Date:  2019-10-08       Impact factor: 13.837

7.  Cannabinoid signalling inhibits sarcoplasmic Ca2+ release and regulates excitation-contraction coupling in mammalian skeletal muscle.

Authors:  Tamás Oláh; Dóra Bodnár; Adrienn Tóth; János Vincze; János Fodor; Barbara Reischl; Adrienn Kovács; Olga Ruzsnavszky; Beatrix Dienes; Péter Szentesi; Oliver Friedrich; László Csernoch
Journal:  J Physiol       Date:  2016-10-27       Impact factor: 5.182

Review 8.  Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists.

Authors:  E Kirilly; L Hunyady; G Bagdy
Journal:  J Neural Transm (Vienna)       Date:  2012-09-19       Impact factor: 3.575

Review 9.  Treatment-resistant depression: are animal models of depression fit for purpose?

Authors:  Paul Willner; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

Review 10.  Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression.

Authors:  Ferenc Zádor; Sâmia Joca; Gábor Nagy-Grócz; Szabolcs Dvorácskó; Edina Szűcs; Csaba Tömböly; Sándor Benyhe; László Vécsei
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.